Despite the high heterogeneity of CRC at both the clinical and molecular levels [8], microsatellite instability in tumor cells and mutations in KRAS and BRAF have been shown to have prognostic and predictive significance for CRC patients [2,8]. The gene discussed is KRAS; the disease is colorectal carcinoma.